CBDL (CBD Life Sciences) Other Current Receivables: $0.00 Mil (As of Sep. 2015)


What is CBD Life Sciences Other Current Receivables?

CBD Life Sciences CBDL Other Current Receivables is $0.00 Mil as of Sep. 2015.

CBD Life Sciences's Other Current Receivables for the quarter that ended in Sep. 2015 was $0.00 Mil.

CBD Life Sciences's annual Other Current Receivables increased from Dec. 2012 ($0.00 Mil) to Dec. 2013 ($0.01 Mil) but then declined from Dec. 2013 ($0.01 Mil) to Dec. 2014 ($0.00 Mil).

CBD Life Sciences Other Current Receivables Related Terms

CBD Life Sciences Other Current Receivables Historical Data

* Premium members only.

The historical data trend for CBD Life Sciences's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CBD Life Sciences Other Current Receivables Chart

CBD Life Sciences Annual Data
Trend Dec11 Dec12 Dec13 Dec14
Other Current Receivables
0.00 0.00 0.01 0.00

CBD Life Sciences Quarterly Data
Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CBD Life Sciences Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of $0.00 Mil mean?
CBD Life Sciences (CBDL) has a Other Current Receivables of $0.00 Mil as of Sep. 2015. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on CBD Life Sciences and its competitors.
Is CBD Life Sciences' Other Current Receivables too high?
CBD Life Sciences' current Other Current Receivables is $0.00 Mil.
How does CBD Life Sciences' Other Current Receivables compare to QPAG and ADGO?
CBD Life Sciences' Other Current Receivables of $0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Drug Manufacturers company?
A good Other Current Receivables depends on the Drug Manufacturers industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on CBD Life Sciences and its competitors. CBD Life Sciences's current Other Current Receivables is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CBD Life Sciences stock overvalued right now?
CBD Life Sciences (CBDL) has a current Other Current Receivables of $0.00 Mil. The current Other Current Receivables is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For CBD Life Sciences (CBDL), the current Other Current Receivables is $0.00 Mil as of Sep. 2015. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CBD Life Sciences Business Description

Address 10953 N. Frank Llyod Wright Boulevard, Unit 108, Scottsdale, AZ, USA, 85259
CBD Life Sciences Inc is developing and marketing a line of cannabidiol-based organic products such as hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a full line of pet products.